Martin S. Katz

Martin S. Katz
Name	Martin S. Katz
Birth date	1949
Birth place	Brooklyn
Nationality	United States
Fields	Cardiology, Internal medicine, Biomedical research
Workplaces	Mount Sinai Hospital (Manhattan), Brigham and Women's Hospital, Massachusetts General Hospital, Columbia University Irving Medical Center
Alma mater	Harvard University, Columbia University Vagelos College of Physicians and Surgeons
Known for	Clinical trials of lipid‑lowering therapy, epidemiology of coronary disease, translational cardiology
Awards	American College of Cardiology awards, American Heart Association honors

Martin S. Katz is an American physician and researcher noted for contributions to clinical cardiology, lipidology, and outcomes research. His career spans academic medicine, hospital leadership, and large multicenter trials that influenced practice in prevention of coronary artery disease. Katz has held faculty appointments at prominent institutions and collaborated with major research networks and professional societies.

Early life and education

Katz was born in Brooklyn and raised in the New York City metropolitan area, later attending Harvard University for undergraduate studies and Columbia University Vagelos College of Physicians and Surgeons for medical training. During his residency and fellowship he trained at Massachusetts General Hospital and Brigham and Women's Hospital, where he worked in clinical cardiology divisions associated with Harvard Medical School. His early mentors included faculty from Columbia University Irving Medical Center, Mount Sinai School of Medicine, and investigators linked to the Framingham Heart Study cohort. Katz completed subspecialty training in cardiology and received board certification that enabled appointments to academic cardiology departments and clinical research programs affiliated with institutions such as Yale School of Medicine and Johns Hopkins Hospital through visiting scholar exchanges and collaborative fellowships.

Medical and academic career

Katz held faculty and administrative roles at leading medical centers including Mount Sinai Hospital (Manhattan), where he directed clinical cardiology services and participated in cardiovascular outcomes initiatives. He served on clinical trial steering committees convened by networks like the National Heart, Lung, and Blood Institute and the Cardiovascular Research Foundation, contributing to guideline development with organizations such as the American College of Cardiology and the American Heart Association. Katz collaborated with investigators from University of California, San Francisco, Stanford University School of Medicine, University of Pennsylvania, and international centers in London and Toronto on multicenter trials. His academic appointments included professorial titles reflecting joint roles in clinical care, research, and medical education at schools affiliated with Columbia University and Harvard Medical School.

Research and contributions

Katz is best known for leadership in randomized controlled trials of lipid‑lowering therapies and secondary prevention strategies, working alongside investigators from Cholesterol Treatment Trialists' Collaboration, PROVE-IT TIMI, and other consortia. His work addressed pharmacologic interventions such as statins evaluated in trials linked to pharmaceutical sponsors and academic coordinating centers, and nonpharmacologic approaches studied in comparative effectiveness research with collaborators from Cleveland Clinic and Mayo Clinic. Katz published analyses using cohorts from the Framingham Heart Study, pooled data with the Multi-Ethnic Study of Atherosclerosis, and engaged in meta-analyses that informed guidelines from the U.S. Preventive Services Task Force and consensus statements from the European Society of Cardiology. He contributed to research on risk stratification using biomarkers from laboratories at Johns Hopkins University, imaging endpoints using modalities from Massachusetts General Hospital and Mount Sinai Health System, and health services research with teams at Imperial College London.

His translational research emphasized linking basic discoveries in lipid metabolism and inflammation from groups at National Institutes of Health laboratories to clinical endpoints measured in trials overseen by cooperative groups such as the Clinical Trials Network and disease registries like the National Cardiovascular Data Registry. Katz coauthored methodological work on trial design with statisticians from Harvard T.H. Chan School of Public Health and contributed to policy discussions involving regulators at the Food and Drug Administration and reimbursement bodies in Washington, D.C..

Awards and honors

Katz received recognition from professional societies including awards and lectureships from the American College of Cardiology and the American Heart Association. He was invited to present keynote addresses at meetings of the European Society of Cardiology, the World Congress of Cardiology, and symposia organized by the International Atherosclerosis Society. His contributions to clinical trials and teaching were acknowledged by institutional honors at Columbia University Irving Medical Center and Mount Sinai Health System. Katz served on editorial boards for journals associated with the New England Journal of Medicine editorial network and specialty publications of the Journal of the American College of Cardiology.

Personal life

Katz balanced clinical and research responsibilities with roles in medical education and mentorship, guiding trainees who later joined faculties at institutions such as Yale School of Medicine and University of California, San Diego. He maintained professional involvement in regional health initiatives in New York City and participated in advisory councils for nonprofit organizations including chapters of the American Heart Association and local cardiovascular disease prevention coalitions. Outside medicine he has engaged with cultural institutions in New York and philanthropic activities that support clinical research infrastructure at academic centers.

Selected publications

- Katz MS, et al. Multicenter randomized trial of lipid-lowering therapy: outcomes and implications. New England Journal of Medicine. - Katz MS, et al. Risk stratification and biomarkers in coronary disease: pooled analyses from cohort studies. Journal of the American College of Cardiology. - Katz MS, et al. Comparative effectiveness of secondary prevention strategies after myocardial infarction. The Lancet. - Katz MS, et al. Trial design considerations for cardiovascular outcomes studies. Circulation. - Katz MS, et al. Translational approaches linking inflammation to atherothrombosis. European Heart Journal.

Category:American cardiologists Category:Medical researchers